{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:12:07Z","timestamp":1791306727782,"version":"4.3.1"},"reference-count":50,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"DOI":"10.1210\/me.2007-0124","type":"journal-article","created":{"date-parts":[[2007,10,12]],"date-time":"2007-10-12T00:33:59Z","timestamp":1192149239000},"page":"234-247","source":"Crossref","is-referenced-by-count":79,"title":["Human Immunodeficiency Virus (HIV)-1 Viral Protein R Suppresses Transcriptional Activity of Peroxisome Proliferator-Activated Receptor \u03b3 and Inhibits Adipocyte Differentiation: Implications for HIV-Associated Lipodystrophy"],"prefix":"10.1210","volume":"22","author":[{"given":"Shashi","family":"Shrivastav","sequence":"first","affiliation":[{"name":"Kidney Disease Section (S.S., J.B.K.), National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoshige","family":"Kino","sequence":"additional","affiliation":[{"name":"Section on Pediatric Endocrinology (T.K., T.I., G.P.C.), Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tshaka","family":"Cunningham","sequence":"additional","affiliation":[{"name":"and Laboratory of Viral Disease (T.C., U.S.), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Ichijo","sequence":"additional","affiliation":[{"name":"Section on Pediatric Endocrinology (T.K., T.I., G.P.C.), Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Schubert","sequence":"additional","affiliation":[{"name":"and Laboratory of Viral Disease (T.C., U.S.), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Institute of Virology (U.S.), University of Erlangen, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Heinklein","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry (P.H.), Humboldt University, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Chrousos","sequence":"additional","affiliation":[{"name":"Section on Pediatric Endocrinology (T.K., T.I., G.P.C.), Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892"},{"name":"First Department of Pediatrics (G.P.C.), University of Athens, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Kopp","sequence":"additional","affiliation":[{"name":"Kidney Disease Section (S.S., J.B.K.), National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041123323358200_R1"},{"key":"2019041123323358200_R2","first-page":"70","article-title":"Metabolic complications of antiretroviral therapy.","volume":"13","author":"Sweet","year":"2005","journal-title":"Top HIV Med"},{"key":"2019041123323358200_R3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.qai.0000167478.28051.3a","article-title":"Redefining lipodystrophy syndrome: risks and impact on clinical decision making.","volume":"39","author":"Lichtenstein","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019041123323358200_R4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-201X.2004.01383.x","article-title":"Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors.","volume":"183","author":"Rudich","year":"2005","journal-title":"Acta Physiol Scand"},{"key":"2019041123323358200_R5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1310\/BRE5-448N-WUPU-JWVL","article-title":"Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response.","volume":"2","author":"Boufassa","year":"2001","journal-title":"HIV Clin Trials"},{"key":"2019041123323358200_R6"},{"key":"2019041123323358200_R7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/ajcn\/82.4.850","article-title":"Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons.","volume":"82","author":"Visnegarwala","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"2019041123323358200_R8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity.","volume":"10","author":"Evans","year":"2004","journal-title":"Nat Med"},{"key":"2019041123323358200_R9","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1128\/JVI.67.12.7229-7237.1993","article-title":"Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.","volume":"67","author":"Paxton","year":"1993","journal-title":"J Virol"},{"key":"2019041123323358200_R10","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1073\/pnas.91.15.7311","article-title":"The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.","volume":"91","author":"Heinzinger","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123323358200_R11","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/JVI.69.11.6705-6711.1995","article-title":"Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.","volume":"69","author":"He","year":"1995","journal-title":"J Virol"},{"key":"2019041123323358200_R12","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1128\/JVI.69.10.6304-6313.1995","article-title":"The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.","volume":"69","author":"Jowett","year":"1995","journal-title":"J Virol"},{"key":"2019041123323358200_R13","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1128\/JVI.69.11.6859-6864.1995","article-title":"Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.","volume":"69","author":"Re","year":"1995","journal-title":"J Virol"},{"key":"2019041123323358200_R14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1084\/jem.193.4.509","article-title":"Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2.","volume":"193","author":"Jacotot","year":"2001","journal-title":"J Exp Med"},{"key":"2019041123323358200_R15","first-page":"11","article-title":"Identification of HIV-1 vpr product and function.","volume":"3","author":"Cohen","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019041123323358200_R16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.189.1.51","article-title":"The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor.","volume":"189","author":"Kino","year":"1999","journal-title":"J Exp Med"},{"key":"2019041123323358200_R17","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1128\/JVI.74.17.8159-8165.2000","article-title":"Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G2 cell cycle arrest.","volume":"74","author":"Sherman","year":"2000","journal-title":"J Virol"},{"key":"2019041123323358200_R18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tem.2007.03.003","article-title":"Virus-mediated modulation of the host endocrine signaling systems: clinical implications.","volume":"18","author":"Kino","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"2019041123323358200_R19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0960-0760(98)00144-7","article-title":"Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions.","volume":"69","author":"McKenna","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041123323358200_R20","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1128\/JVI.76.19.9724-9734.2002","article-title":"Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300\/CBP coactivators.","volume":"76","author":"Kino","year":"2002","journal-title":"J Virol"},{"key":"2019041123323358200_R21","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1073\/pnas.91.23.10873","article-title":"Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1.","volume":"91","author":"Levy","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123323358200_R22","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.4049\/jimmunol.169.11.6361","article-title":"HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection.","volume":"169","author":"Mirani","year":"2002","journal-title":"J Immunol"},{"key":"2019041123323358200_R23","doi-asserted-by":"crossref","first-page":"32016","DOI":"10.1074\/jbc.M004044200","article-title":"Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest.","volume":"275","author":"Henklein","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041123323358200_R24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.281.5374.266","article-title":"Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents.","volume":"281","author":"Poon","year":"1998","journal-title":"Science"},{"key":"2019041123323358200_R25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1152\/physrev.1998.78.3.783","article-title":"Understanding adipocyte differentiation.","volume":"78","author":"Gregoire","year":"1998","journal-title":"Physiol Rev"},{"key":"2019041123323358200_R26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biocel.2006.08.017","article-title":"Pregnane X receptor: promiscuous regulator of detoxification pathways.","volume":"39","author":"Matic","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"2019041123323358200_R27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1210\/jcem-64-4-832","article-title":"Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells.","volume":"64","author":"Hauner","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123323358200_R28","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1074\/jbc.275.13.9131","article-title":"Cloning and characterization of a functional peroxisome proliferator activator receptor-\u03b3-responsive element in the promoter of the CAP gene.","volume":"275","author":"Baumann","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041123323358200_R29","doi-asserted-by":"crossref","first-page":"28488","DOI":"10.1074\/jbc.M004029200","article-title":"Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.","volume":"275","author":"Kersten","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041123323358200_R30","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1093\/nar\/22.25.5628","article-title":"Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR\u03b3 and RXR\u03b1.","volume":"22","author":"Tontonoz","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"2019041123323358200_R31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR\u03b3 2, a lipid-activated transcription factor.","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"2019041123323358200_R32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/83336","article-title":"PPAR-\u03b3 dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation.","volume":"7","author":"Chawla","year":"2001","journal-title":"Nat Med"},{"key":"2019041123323358200_R33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1096\/fj.01-0947fje","article-title":"Human adipose cells express CD4, CXCR4, and CCR5 [corrected] receptors: a new target cell type for the immunodeficiency virus-1?","volume":"16","author":"Hazan","year":"2002","journal-title":"FASEB J [Erratum (2002) 16:4]"},{"key":"2019041123323358200_R34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/viro.2002.1576","article-title":"HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis.","volume":"302","author":"Sherman","year":"2002","journal-title":"Virology"},{"key":"2019041123323358200_R35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(05)60294-2","article-title":"A \u201cBuffalo hump\u201d in HIV-1 infection.","volume":"352","author":"Luca","year":"1998","journal-title":"Lancet"},{"key":"2019041123323358200_R36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults.","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041123323358200_R37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0960-0760(03)00218-8","article-title":"Tissue glucocorticoid resistance\/hypersensitivity syndromes.","volume":"85","author":"Kino","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041123323358200_R38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(05)60295-4","article-title":"\u201cBuffalo hump\u201d in HIV-1 infection.","volume":"352","author":"Stocker","year":"1998","journal-title":"Lancet"},{"key":"2019041123323358200_R39","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1210\/jcem.84.6.5740","article-title":"Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy.","volume":"84","author":"Yanovski","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123323358200_R40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"2019041123323358200_R41","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0140-6736(05)64011-1","article-title":"Benign symmetric lipomatosis associated with protease inhibitors.","volume":"350","author":"Hengel","year":"1997","journal-title":"Lancet"},{"key":"2019041123323358200_R42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1358\/mf.2002.24.8.705072","article-title":"Experimental approaches to study PPAR\u03b3 agonists as antidiabetic drugs.","volume":"24","author":"Vazquez","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"2019041123323358200_R43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.nutr.22.010402.102808","article-title":"PPAR\u03b3 and glucose homeostasis.","volume":"22","author":"Picard","year":"2002","journal-title":"Annu Rev Nutr"},{"key":"2019041123323358200_R44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-7-3","article-title":"Peroxisomal proliferator activated receptor-\u03b3 deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3).","volume":"7","author":"Francis","year":"2006","journal-title":"BMC Med Genet"},{"key":"2019041123323358200_R45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/mend.11.6.0018","article-title":"Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes.","volume":"11","author":"Soderstrom","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041123323358200_R46","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1074\/jbc.274.10.6718","article-title":"Novel peroxisome proliferator-activated receptor (PPAR) \u03b3 and PPAR\u03b4 ligands produce distinct biological effects.","volume":"274","author":"Berger","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041123323358200_R47","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.2001.81.3.1269","article-title":"Nuclear hormone receptors and gene expression.","volume":"81","author":"Aranda","year":"2001","journal-title":"Physiol Rev"},{"key":"2019041123323358200_R48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1677\/joe.0.1690437","article-title":"Glucocorticoid and mineralocorticoid resistance\/hypersensitivity syndromes.","volume":"169","author":"Kino","year":"2001","journal-title":"J Endocrinol"},{"key":"2019041123323358200_R49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.biochem.70.1.341","article-title":"Peroxisome proliferator-activated receptor \u03b3 and metabolic disease.","volume":"70","author":"Willson","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"2019041123323358200_R50","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1016\/S0021-9258(17)34541-6","article-title":"Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells.","volume":"253","author":"Rubin","year":"1978","journal-title":"J Biol Chem"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/22\/2\/234\/10719790\/mend0234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T16:36:22Z","timestamp":1737477382000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/22\/2\/234\/2660995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,1]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2007-0124","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,1]]}}}